Evidence map›Paper›PMID 32179510›Full record

Observational studyDiabetes care2020

Evaluation of Factors Related to Glycemic Management in Professional Cyclists With Type 1 Diabetes Over a 7-Day Stage Race.

Sam N Scott, Mark P Christiansen, Federico Y Fontana, Christoph Stettler, Richard M Bracken, Charlotte A Hayes, Miles Fisher, Bruce Bode, Peter H Lagrou, Phil Southerland and 1 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Diabetes care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Review
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 5 countries.

Sam N ScottSchool of Kinesiology and Health Science, York University, Toronto, Ontario, Canada sam-scott@live.co.uk.ORCID 0000-0003-2342-9865
Mark P ChristiansenDiablo Clinical Research, Walnut Creek, CA.
Federico Y FontanaTeam Novo Nordisk Professional Cycling Team, Atlanta, GA.
Christoph StettlerDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0003-1691-6059
Richard M BrackenApplied Sport, Technology, Exercise and Medicine (A-STEM), Swansea University, Swansea, U.K.
Charlotte A HayesTeam Novo Nordisk Professional Cycling Team, Atlanta, GA.
Miles FisherDepartment of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, Glasgow, Scotland, U.K.
Bruce BodeAtlanta Diabetes Associates, Atlanta, GA.
Peter H LagrouTeam Novo Nordisk Professional Cycling Team, Atlanta, GA.
Phil SoutherlandTeam Novo Nordisk Professional Cycling Team, Atlanta, GA.
Michael C RiddellSchool of Kinesiology and Health Science, York University, Toronto, Ontario, Canada.ORCID 0000-0001-6556-7559
Novo Nordisk (United States) · USUniversity of Bern · CHAtlanta Diabetes Associates · USDiablo Clinical Research · USGlasgow Royal Infirmary · GBSwansea University · GBUniversity of Verona · ITYork University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate factors related to glycemic management among members of a professional cycling team with type 1 diabetes over a 7-day Union Cycliste Internationale World Tour stage race. RESEARCH DESIGN AND

methodsAn observational evaluation of possible factors related to glycemic management and performance in six male professional cyclists with type 1 diabetes (HbA

resultsIn-ride time spent in euglycemia (3.9-10.0 mmol/L glucose) was 63 ± 11%, with a low percentage of time spent in level 1 (3.0-3.9 mmol/L; 0 ± 1% of time) and level 2 (<3.0 mmol/L; 0 ± 0% of time) hypoglycemia over the 7-day race. Riders spent 25 ± 9% of time in level 1 (10.1-13.9 mmol/L) and 11 ± 9% in level 2 (>13.9 mmol/L) hyperglycemia during races. Bolus insulin use was uncommon during races, despite high carbohydrate intake (76 ± 23 g ⋅ h

conclusionsProfessional cyclists with type 1 diabetes have excellent in-race glycemia, but significant hypoglycemia during recovery overnight, throughout a 7-day stage race.

Indexed as

AthletesGlycemic ControlAdultBicyclingBlood GlucoseBlood Glucose Self-MonitoringCaliforniaCompetitive BehaviorDiabetes Mellitus, Type 1HumansHypoglycemic AgentsInsulinMaleSelf-ManagementTime FactorsBlood GlucoseHypoglycemic AgentsInsulin

Identifiers

PMID32179510
PMCPMC7171953
OpenAlexW3012094079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.